MedTrace Logo

ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

NCT00385021 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-11-02

No results posted yet for this study

Summary

To determine efficacy in the delivery of chronomodulated chemotherapy.

Conditions

  • Colorectal Neoplasms

Interventions

DRUG

5-Fluorouracil, leucovorin, oxaliplatin, avastin

Sponsors & Collaborators

  • Southwestern Regional Medical Center

    lead OTHER

Principal Investigators

  • Petra Ketterl, MD · Cancer Treatment Centers of America at Southwestern Regional Medical Center, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
86 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00385021 on ClinicalTrials.gov